GlassScriptPhysician profile
Aubrey Hall
NPI 1780026393
$8,261.98
in general payments reported to CMS, 2019-2025
18 companies · $528 in 2025
The $528 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,858 · 2022: $3,921 · 2023: $1,604 · 2024: $351 · 2025: $528.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,151 · Travel and Lodging: $332.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,150.86 |
| Travel and Lodging | $332.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $4,702.81 | 2021-2025 | |
| Abbott Laboratories | $1,536.78 | 2021-2024 | Mitraclip, Jot Dx |
| Cvrx, INC. | $473.61 | 2023-2024 | Barostim Neo System |
| Amgen INC. | $282.76 | 2023-2025 | Repatha, Imdelltra (Amg757) |
| Pfizer INC. | $218.69 | 2023-2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $212.54 | 2021-2023 | Jardiance |
| Integra Lifesciences Corporation | $197.51 | 2025 | Codman Hakim, Cusa Clarity, Codman Certas |
| Astrazeneca Pharmaceuticals LP | $187.46 | 2021-2024 | Farxiga |
| Medtronic, INC. | $123.86 | 2021 | |
| Novartis Pharmaceuticals Corporation | $90.47 | 2023-2025 | |
| Impulse Dynamics (USA) INC. | $52.23 | 2023-2024 | Optimizer, Optimizer |
| Abiomed | $38.10 | 2023 | Impella |
| Bayer Healthcare Pharmaceuticals INC. | $31.36 | 2023 | |
| Janssen Pharmaceuticals, INC | $30.81 | 2023 | Xarelto |
| Baxter Healthcare | $28.22 | 2023 | Hillrom - Carnation Ambulatory Monitor |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kiniksa Pharmaceuticals, LTD. | $19.46 | 2023 | Arcalyst |
| Inspire Medical Systems, INC. | $18.79 | 2023 | Inspire |
| Cardiva Medical, INC. | $16.52 | 2023 | Cardiva Vascade 6/7f Vcs |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aubrey Hall listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.